Beste apotheek van Nederland

133. Olsson AM, Persson CA, Swedish Sildenafil
Investigators Group. Efficacy and safety of
sildenafil citrate for the treatment of erectile
dysfunction in men with cardiovascular disease.
Int J Clin Pract 2001 Apr;55(3):171-6.
134. Montorsi F, Maga T, Strambi LF, et al.
Sildenafil taken at bedtime significantly increases
nocturnal erections: results of a placebocontrolled
study. Urology 2000 Dec
20;56(6):906-11.
135. Cappelleri JC, Siegel RL, Osterloh IH, et al.
Relationship between patient self-assessment of
erectile function and the erectile function domain
of the international index of erectile function.
Urology 2000 Sep 1;56(3):477-81.
136. Palmer JS, Kaplan WE, Firlit CF. Erectile
dysfunction in spina bifida is treatable. Lancet
1999 Jul 10;354(9173):125-6.
137. Montorsi F, McDermott TE, Morgan R, et al.
Efficacy and safety of fixed-dose oral sildenafil
in the treatment of erectile dysfunction of various
etiologies. Urology 1999 May;53(5):1011-8.
138. Dinsmore WW, Hodges M, Hargreaves C, et al.
Sildenafil citrate (Viagra) in erectile dysfunction:
near normalization in men with broad-spectrum
erectile dysfunction compared with age-matched
healthy control subjects.[erratum appears in
Urology 1999 May;53(5):1072]. Urology 1999
Apr;53(4):800-5.
139. Eardley I, Brooks J, Yates PK, et al. Sildenafil
citrate (VIAGRA): an oral treatment for erectile
function with activity for up to four hours'
duration. Int J Clin Pract 1999 Jun;102(Suppl
Jun.):102-4.
140. Hartmann U, Meuleman EJ, Cuzin B, et al.
Sildenafil citrate (VIAGRA): analysis of
preferred doses in a European, six-month,
double-blind, placebo-controlled, flexible doseescalation
study in patients with erectile
dysfunction. Multicentre Study Group. Int J Clin
Pract 1999 Jun;102(Suppl Jun.):102-9.
141. Young J. Sildenafil citrate (VIAGRA) in the
treatment of erectile dysfunction: a 12-week,
flexible-dose study to assess efficacy and safety.
Int J Clin Pract 1999 Jun;102(Suppl Jun.):6-7.
142. Padma-Nathan H, Steers WD, Wicker PA.
Efficacy and safety of oral sildenafil in the
treatment of erectile dysfunction: a double-blind,
placebo-controlled study of 329 patients.
Sildenafil Study Group. Int J Clin Pract 1998
Sep;52(6):375-9.
143. Albuquerque DC, Miziara LJ, Saraiva JFK, et al.
Efficacy, safety and tolerability of sildenafil in
Brazilian hypertensive patients on multiple
antihypertensive drugs. Int Braz J Urol
2005;31(4):342-55.
144. Yonessi M, Saeedi M. A double-blind placebocontrolled
evaluation of the effect of topical
sildenafil on erectile dysfunction. J App Res
2005;5(2):289-94.
145. Shamloul R, Ghanem H, Fahmy I, et al.
Testosterone therapy can enhance erectile
function response to sildenafil in patients with
PADAM: A pilot study. J Sex Med
2005;2(4):559-64.
146. Gingell C, Sultana SR, Wulff MB, et al.
Duration of action of sildenafil citrate in men
with erectile dysfunction. J Sex Med
2004;1(2):179-84.
147. Pickering TG, Shepherd AMM, Puddey I, et al.
Sildenafil citrate for erectile dysfunction in men
receiving multiple antihypertensive agents: A
randomized controlled trial. Am J Hypertens
2004;17(12):1135-42.
148. Pavone C, Curto F, Anello G, et al. Prospective,
randomized, crossover comparison of sublingual
apomorphine (3 mg) with oral sildenafil (50 mg)
for male erectile dysfunction. J Urol 2004;172(6
Pt 1):2347-9.
149. Bawa AS, Sharma DR, Singh R, et al. Efficacy
and tolerability of sildenafil in Indian males with
erectile dysfunction: A double-blind, randomized,
placebo-controlled, crossover study. Indian J
Pharmacol 2004;36(5):317
150. Dunzendorfer U, Behm A, Dunzendorfer E, et al.
Drug combinations in the therapy of low
response to phosphodiesterase 5 inhibitors in
patients with erectile dysfunction. In Vivo
2002;16(5):345-8.
151. Glina S, Bertero E, Claro J, et al. Efficacy and
safety of sildenafil citrate for the treatment of
erectile dysfunction in Latin America. Braz J
Urol 2001;27(2):148-54.
152. Barry MJ. Sildenafil improved sexual function in
erectile dysfunction. Int J Impot Res
1998;3(6):184
213